Skip to main content
Rase AI Intelligence Newsletter

Research & education Industry development

Isomorphic Labs announces $5 billion Series C funding

Isomorphic Labs announced $5 billion in Series C funding to expand its AI drug-design engine, therapeutic-candidate programs and bioengineering infrastructure. [1][2]

Development status
Funding announced for AI-led drug design and candidate development [1][2]

What happened

The official announcement identifies Greenoaks and Sequoia Capital as co-leads. Its accompanying release describes development of IsoDDE and work toward clinical trials. [1][2]

Why it matters

The financing supports AI-led drug discovery and the infrastructure needed to investigate whether computationally designed candidates can become medicines. [1][2]

Key dates

  1. Isomorphic Labs announces $5 billion Series C funding [1][2]

Risks and open questions

Reported preclinical progress is a company statement. The announcement does not establish clinical efficacy, a completed trial, regulatory approval or an available medicine. [1][2]

Sources and verification

Catalog evidence checked How we verify records

  1. Primary source Isomorphic Labs announces Series C investment round
  2. Primary source Isomorphic Labs November 17 funding release

Related profiles

Research & education

NVIDIA Nemotron for Science

NVIDIA

The collection packages technical components for researchers and scientific computing teams.

High confidenceEvidence checked

Research & education

GraphCast

Google DeepMind

Uses recent atmospheric states to predict future weather variables including wind, temperature and air pressure.

High confidenceEvidence checked

Research & education

Khanmigo

Khan Academy

It provides guided practice and supports teaching tasks through an education-focused chat interface.

High confidenceEvidence checked